title: Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet.
abstract: FGF21 is a secreted protein that plays critical roles in regulating glucose and lipid metabolism. In this study, we evaluated the effects of FGF21 gene transfer on C57BL/6 mice fed a high fat diet (HFD). We demonstrate that transfer of the FGF21 gene using a hydrodynamics-based procedure increased mRNA levels of FGF21 exclusively in the liver, consequently generating a sustained high level of FGF21 protein in blood that peaked at 500 ng/ml 1 day after injection, leading to a variety of beneficial effects including blockade of HFD-induced obesity, alleviation of fatty liver and improvement in glucose homeostasis. These effects were associated with altered expression of Ucp1, Dio2, Pgc1α, Pparγ2, Mgat1, F4/80, Mcp1 and Tnfα, which are involved in thermogenesis, lipogenesis and chronic inflammation in the liver and adipose tissues. Transfer of the FGF21 gene in HFD-induced obese mice greatly increased the expression of thermogenic genes in adipose tissue, resulting in similar improvements in systemic metabolism including reduction of adiposity, alleviation of fatty liver and attenuation of insulin resistance. Mechanistic studies on the effects of FGF21 gene transfer in lean mice revealed that mice transferred with FGF21 gene displayed suppressed lipogenesis in the liver and enhanced thermogenesis in brown adipose tissue which was coincident with a significant improvement in glucose tolerance. Collectively, our results suggest that transfer of the FGF21 gene could be considered a promising approach for treating obesity and its complications.
authors.affiliation: Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA, USA.
authors.forename: Mingming
authors.initials: M
authors.lastname: Gao
authors.affiliation: Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA, USA.
authors.forename: Yongjie
authors.initials: Y
authors.lastname: Ma
authors.affiliation: Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA, USA.
authors.forename: Ran
authors.initials: R
authors.lastname: Cui
authors.affiliation: Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA, USA. Electronic address: dliu@uga.edu.
authors.forename: Dexi
authors.initials: D
authors.lastname: Liu
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism / Q000473:pathology; D000818:Animals; D001835:Body Weight; D004247:DNA / Q000008:administration & dosage* / Q000235:genetics / Q000627:therapeutic use*; D059305:Diet, High-Fat / Q000009:adverse effects; D005234:Fatty Liver / Q000209:etiology / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D005346:Fibroblast Growth Factors / Q000032:analysis / Q000235:genetics*; D005786:Gene Expression Regulation; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005947:Glucose / Q000378:metabolism; D057446:Hydrodynamics; D007333:Insulin Resistance; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese; D009765:Obesity / Q000209:etiology / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D022722:Thermogenesis
chemical_list: C414620:fibroblast growth factor 21; D005346:Fibroblast Growth Factors; D004247:DNA; D005947:Glucose
keywords: Diabetes; FGF21; Fatty liver; Hydrodynamic gene delivery; Obesity; Thermogenesis
references.citation: Endocrinology. 2007 Feb;148(2):774-81
references.pmid: 17068132
references.citation: Mol Med. 2011;17(7-8):736-40
references.pmid: 21373720
references.citation: Bioconjug Chem. 2013 Jun 19;24(6):915-25
references.pmid: 23594041
references.citation: Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1105-14
references.pmid: 19706786
references.citation: BioDrugs. 2013 Apr;27(2):159-66
references.pmid: 23456652
references.citation: PLoS One. 2013 Jun 07;8(6):e65641
references.pmid: 23762402
references.citation: AAPS J. 2013 Jul;15(3):744-52
references.pmid: 23591747
references.citation: Clin Ther. 2002 Nov;24(11):1720-40; discussion 1719
references.pmid: 12501870
references.citation: Diabetes. 2009 Jan;58(1):250-9
references.pmid: 18840786
references.citation: J Cell Physiol. 2007 Jan;210(1):1-6
references.pmid: 17063460
references.citation: J Clin Invest. 2003 Dec;112(12):1796-808
references.pmid: 14679176
references.citation: Diabetes. 2012 Feb;61(2):505-12
references.pmid: 22210323
references.citation: Int J Obes (Lond). 2014 Feb;38(2):170-6
references.pmid: 23736373
references.citation: Hum Gene Ther. 1999 Jul 1;10(10):1735-7
references.pmid: 10428218
references.citation: J Biol Chem. 2011 Apr 15;286(15):12983-90
references.pmid: 21317437
references.citation: Mol Ther. 2013 Oct;21(10):1852-61
references.pmid: 23774795
references.citation: Curr Opin Investig Drugs. 2009 Apr;10(4):359-64
references.pmid: 19337957
references.citation: Int J Biochem Cell Biol. 2013 Mar;45(3):546-9
references.pmid: 23270727
references.citation: Endocrinology. 2013 Sep;154(9):3099-109
references.pmid: 23766126
references.citation: Drug Discov Today. 2014 May;19(5):579-89
references.pmid: 24189035
references.citation: J Clin Invest. 2003 Dec;112(12):1821-30
references.pmid: 14679177
references.citation: PLoS One. 2012;7(11):e49345
references.pmid: 23209571
references.citation: Curr Opin Pharmacol. 2009 Dec;9(6):805-10
references.pmid: 19683963
references.citation: BioDrugs. 2008;22(1):37-44
references.pmid: 18215089
references.citation: Gene Ther. 1999 Jul;6(7):1258-66
references.pmid: 10455434
references.citation: Diabetes. 2006 Sep;55(9):2470-8
references.pmid: 16936195
references.citation: Diabetes Metab Res Rev. 2011 Mar;27(3):286-97
references.pmid: 21309058
references.citation: Endocrinology. 2008 Dec;149(12):6018-27
references.pmid: 18687777
references.citation: Nat Med. 2013 Jan;19(1):83-92
references.pmid: 23202295
references.citation: J Biol Chem. 2012 Jul 27;287(31):26060-7
references.pmid: 22696219
references.citation: Cell Metab. 2007 Jun;5(6):426-37
references.pmid: 17550778
references.citation: Cell Metab. 2010 Mar 3;11(3):206-12
references.pmid: 20197053
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3143-8
references.pmid: 22315431
references.citation: J Clin Invest. 2005 Jun;115(6):1627-35
references.pmid: 15902306
references.citation: Diabetes. 2010 Jul;59(7):1817-24
references.pmid: 20357365
references.citation: Pharm Res. 2013 Nov;30(11):2940-50
references.pmid: 23783345
references.citation: PLoS One. 2011;6(6):e20669
references.pmid: 21673953
references.citation: Cell. 2012 Feb 3;148(3):556-67
references.pmid: 22304921
references.citation: Genes Dev. 2012 Feb 1;26(3):271-81
references.pmid: 22302939